Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Current Deferred Revenue (2019 - 2025)

Cellebrite DI has reported Current Deferred Revenue over the past 7 years, most recently at $277.6 million for Q4 2025.

  • Quarterly results put Current Deferred Revenue at $277.6 million for Q4 2025, up 5.86% from a year ago — trailing twelve months through Dec 2025 was $277.6 million (up 5.86% YoY), and the annual figure for FY2025 was $277.6 million, up 5.86%.
  • Current Deferred Revenue for Q4 2025 was $277.6 million at Cellebrite DI, up from $262.2 million in the prior quarter.
  • Over the last five years, Current Deferred Revenue for CLBT hit a ceiling of $277.6 million in Q4 2025 and a floor of $159.4 million in Q4 2021.
  • Median Current Deferred Revenue over the past 5 years was $242.8 million (2023), compared with a mean of $227.4 million.
  • Biggest five-year swings in Current Deferred Revenue: grew 24.6% in 2023 and later increased 5.86% in 2025.
  • Cellebrite DI's Current Deferred Revenue stood at $159.4 million in 2021, then increased by 22.25% to $194.9 million in 2022, then rose by 24.6% to $242.8 million in 2023, then rose by 7.99% to $262.2 million in 2024, then grew by 5.86% to $277.6 million in 2025.
  • The last three reported values for Current Deferred Revenue were $277.6 million (Q4 2025), $262.2 million (Q4 2024), and $242.8 million (Q4 2023) per Business Quant data.